NCT02796768

Brief Summary

Ultrasound imaging (US), a radiation-free imaging modality, is currently used in diagnosis of developmental dysplasia of the hip (DDH) in infants. The current protocol involves manually identifying specific measures that are prone to error, and may give rise to false positives. We aim to use 2-dimensional (2D) and 3-dimensional (3D) ultrasound imaging to create an automatic measurement procedure that we hope will reduce the errors in measurement and increase reliability.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2014

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

May 26, 2016

Completed
18 days until next milestone

First Posted

Study publicly available on registry

June 13, 2016

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

June 13, 2016

Status Verified

June 1, 2016

Enrollment Period

2.5 years

First QC Date

May 26, 2016

Last Update Submit

June 7, 2016

Conditions

Outcome Measures

Primary Outcomes (2)

  • Alpha angles automatically extracted from 3D US images as a measure of dysplasia of the infant hip

    Baseline

  • Alpha angles automatically extracted/measured from 2D US images as a measure of dysplasia of the infant hip

    Baseline

Secondary Outcomes (4)

  • Beta angles automatically extracted from 3D US images as a measure of dysplasia of the infant hip

    Baseline

  • Beta angles automatically extracted/measured from 2D US images as a measure of dysplasia of the infant hip

    Baseline

  • Femoral head coverage automatically extracted from 3D US images as a measure of dysplasia of the infant hip

    Baseline

  • Femoral head coverage automatically extracted/measured from 2D US images as a measure of dysplasia of the infant hip

    Baseline

Study Arms (1)

Participants

Study participants will be 0 to 4 months of age and undergoing DDH screening. They will have the following scans: BASELINE - 1 3D US scanning session of right and left hip by Specialist 1, 1 3D US scanning session of right and left hip by Specialist 2, 1 2D US scanning session of right and left hip by Specialist 1, 1 2D US scanning session of right and left hip by Specialist 2. FOLLOW-UP (OPTIONAL) - 1 3D US scanning session of right and left hip by Specialist 1, 1 3D US scanning session of right and left hip by Specialist 2, 1 2D US scanning session of right and left hip by Specialist 1, 1 2D US scanning session of right and left hip by Specialist 2.

Other: 3D US ScanningOther: 2D US Scanning

Interventions

3D ultrasound will be used by both clinicians to scan both the right and left hips of the infant.

Participants

2D ultrasound will be used by both clinicians to scan both the right and left hips of the infant.

Participants

Eligibility Criteria

AgeUp to 4 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Infants that have been referred to the Orthopaedic Clinic at our institution for suspected or diagnosed Developmental Dysplasia of the Hip (DDH).

You may qualify if:

  • Children with suspected DDH at our institution
  • Ages 0 to 4 months of age

You may not qualify if:

  • US not performed at our institution
  • No diagnosis of DDH or not suspected of having DDH
  • Other congenital hip abnormalities or genetic syndromes
  • Patient/family does not live in the Lower Mainland

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

British Columbia Children's Hospital

Vancouver, British Columbia, V6H 3V4, Canada

RECRUITING

MeSH Terms

Conditions

Developmental Dysplasia of the Hip

Condition Hierarchy (Ancestors)

Hip DislocationJoint DislocationsJoint DiseasesMusculoskeletal DiseasesMusculoskeletal AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Kishore Mulpuri, MBBS, MS(Ortho), MHSc

    Provincial Health Services Authority British Columbia

    PRINCIPAL INVESTIGATOR
  • Antony Hodgson, BASc, MASc, PhD

    University of British Columbia

    PRINCIPAL INVESTIGATOR
  • Anthony Cooper, BSc, MBChB, FRCS

    Provincial Health Services Authority British Columbia

    PRINCIPAL INVESTIGATOR
  • Rafeef Abugharbieh, BSc, MSc, PhD

    University of British Columbia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kishore Mulpuri, MBBS, MS(Ortho), MHSc

CONTACT

Emily Schaeffer, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pediatric Orthopaedic Surgeon

Study Record Dates

First Submitted

May 26, 2016

First Posted

June 13, 2016

Study Start

December 1, 2014

Primary Completion

June 1, 2017

Study Completion

June 1, 2017

Last Updated

June 13, 2016

Record last verified: 2016-06

Data Sharing

IPD Sharing
Will not share

Locations